Compliance with vaccination recommendations among patients with multiple myeloma: a real world experience

Abstract: Infections are the second leading cause of death in multiple myeloma (MM), after the disease itself. A large retrospective population-based study revealed a 7-fold higher risk for bacterial and a 10-fold increased risk for viral infections in MM patients compared with population-based controls and showed a particularly high risk shortly after start of therapy.1 Hence, all available measures to curb this complication should be exploited. These include antibiotic prophylaxis in selected cases, antiviral prophylaxis of well-defined risk groups,2 and vaccination against several bacteria and viruses.3 Recently, recommendations for vaccination against various pathogens have been updated.3 In this study, we assessed the type of recommendations provided to MM patients in real-word clinical practice and their compliance with them. Moreover, we surveyed the incidence of infections before and after onset of antimyeloma therapy and patients’ willingness to be vaccinated against coronavirus disease 2019 (COVID-19)

Object Details

• Location: Deutsche Nationalbibliothek Frankfurt am Main
• Extent: Online-Ressource
• Language: Englisch
• Notes: HemaSphere. - 5, 7 (2021) , e597, ISSN: 2572-9241

Contributors, Places and Time

• Event: Veröffentlichung
• (where): Freiburg
• (who): Universität
• (when): 2021
• Creator: Ludwig, Heinz ; Meckl, Angela ; Engelhardt, Monika

Further information

• DOI: 10.1097/hs9.0000000000000597
• URN: urn:nbn:de:bsz:25-freidok-2196197
• Rights: Kein Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
• Last update: 25.03.2025, 1:53 PM CET